Sirolimus treatment for intractable vascular anomalies ( <scp>SIVA</scp> ): An open‐label, single‐arm, multicenter, prospective trial

Sirolimus may reduce VA tissue volume and potentially improve symptoms and activities of daily living in patients with VAs.

Authors

Institutions

Publication Details

Journal
Pediatrics International
Published
2025-01-01
DOI
https://doi.org/10.1111/ped.70002
Citations
3
Primary Topic
Vascular Malformations and Hemangiomas
Type
article
Field-Weighted Citation Impact
6.02

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Sirolimus treatment for intractable vascular anomalies ( SIVA ): An open‐label, single‐arm, multicenter, prospective trial

Akihiro Fujino, Kyoichi Deie, Michio Ozeki, Junkichi Takemoto et al.
3 citations
Pediatrics International
Vascular Malformations and Hemangiomas
6.02
article

Sirolimus treatment for intractable vascular anomalies ( SIVA ): An open‐label, single‐arm, multicenter, prospective trial

Akihiro Fujino, Kyoichi Deie, Michio Ozeki, Junkichi Takemoto, Takanobu Maekawa, Akihiro Umezawa, Mikiko Miyasaka, Shiho Yasue, Shigehisa Fumino, Motoi Kato, Hiroya Hashimoto, Naonori Kawakubo, Shunsuke Nosaka, Akiko Saito, Ryuta Asada, Tatsuo Kuroda, Shigeru Ueno, Satoshi Hirakawa, Saori Endo, Mototoshi Kato, Tatsuro Tajiri, Taizo Furukawa, Kentaro Matsuoka, Shôji Watanabe
article en
3 citations

Abstract

Sirolimus may reduce VA tissue volume and potentially improve symptoms and activities of daily living in patients with VAs.

Pediatrics InternationalVol. 67(1)
Tokai University (JP), Kyushu University (JP), Keio University (JP), Hamamatsu University School of Medicine (JP), Nagoya City University (JP), Kyoto Prefectural University of Medicine (JP), Saitama Children's Medical Center (JP), Okayama University Hospital (JP), National Center For Child Health and Development (JP), Tokyo Metropolitan Children's Medical Center (JP), Nagoya Medical Center (JP), Gifu University (JP), Kitasato University (JP)
Japan Agency for Medical Research and Development
No poverty
Openalex Percentile: Top 5%
Vascular Malformations and Hemangiomas
6.02
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.